The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Global

banner

Kane Biotech Issued Additional Patent on Biofilm Technology

09-Feb-2011 | Source : AG-IP News | Visits : 7416

WINNIPEG, MANITOBA - Kane Biotech Inc., a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, announced in a press release the issuance of Patent No. 564904 entitled “Antimicrobial Compositions and Uses Thereof” by the New Zealand IP office.

Aledex is a synergistic and broad-spectrum combination of Protamine Sulfate and Chlorhexidine used to prevent microbial growth and biofilm formation. This patent covers the method of preventing growth and proliferation of biofilm-embedded microorganisms on medical devices such as urinary and vascular access catheters.

“We are very pleased that our unique Aledex biofilm technology for medical device coatings has been patented in New Zealand. We now have 14 issued and 28 pending patents covering our biofilm technology platforms” stated Gord Froehlich, President and CEO of Kane Biotech.

Kane Biotech is a biotechnology company engaged in the development of products to prevent and disperse biofilms. Biofilms develop when bacteria and other microorganisms form a protective matrix that acts as a shield against attack. When in a biofilm, bacteria become highly resistant to antibiotics, biocides, disinfectants, high temperatures and host immune responses. This resiliency contributes to human health problems such as recurrent urinary tract infections, medical device associated infections and tooth decay.

share



Related Articles